APA (7th ed.) Citation

Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, & Croce D. (2017). Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]. Dove Medical Press.

Chicago Style (17th ed.) Citation

Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, and Croce D. Budget Impact Analysis of the Simplification to Atazanavir + Ritonavir + Lamivudine Dual Therapy of HIV-positive Patients Receiving Atazanavir-based Triple Therapies in Italy Starting from Data of the Atlas-M Trial [Corrigendum]. Dove Medical Press, 2017.

MLA (9th ed.) Citation

Restelli U, et al. Budget Impact Analysis of the Simplification to Atazanavir + Ritonavir + Lamivudine Dual Therapy of HIV-positive Patients Receiving Atazanavir-based Triple Therapies in Italy Starting from Data of the Atlas-M Trial [Corrigendum]. Dove Medical Press, 2017.